Osso Health Medical Training App Launches for Apple Vision Pro

Osso VR, the leader in immersive procedural training, announces the launch of Osso Health, a medical training app on Apple Vision Pro. Leveraging the power of  Apple Vision Pro to seamlessly blend digital content with the physical world  Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.
Osso Health’s simulated surgical environment for Apple Vision Pro represents a major milestone in democratizing access to procedural education. With this launch, Osso VR is extending its technology to a broader audience, making procedural education accessible to healthcare professionals, patients preparing for surgery, and individuals interested in medical innovation. The Osso Health app is designed to simulate medical procedures at the highest fidelity, seamlessly integrating the operating room into physical spaces and providing on-demand access to hands-on learning from anywhere. visionOS features a brand-new three-dimensional user interface and input system controlled entirely by a user’s eyes, hands, and voice, so Osso Health users can seamlessly and intuitively explore procedures.
The Osso Health app currently lets users engage with surgical workflows for two common orthopedic procedures: Carpal Tunnel Release and Total Knee Replacement. The user can walk through the key steps of each procedure using Apple Vision Pro’s novel approach to spatial computing. Spatial computing has opened up new possibilities for medical professionals to explore complicated medical procedures in a secure, controlled, and real-world setting. Osso VR’s proficiency in medical artistry overlayed onto the real world enhances the authenticity of the training, making it an indispensable tool for medical students, residents, and practicing physicians alike.
“Osso Health for Apple Vision Pro opens up exciting possibilities for the future of immersive procedural education,” said Justin Barad, MD, Co-founder and Chief Strategy Officer at Osso VR. ”Apple Vision Pro unlocks new opportunities to scale spatial computing in healthcare with groundbreaking display quality and virtually lag-free learning experience, helping solve important challenges to education in healthcare.”
To experience the next generation of medical training on Apple Vision Pro, visit Osso Health on the App Store.
SourceOsso VR

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”